Grant: Operating Grant
University of British Columbia
$795,064.00
Regulation of intestinal homeostasis and cancer by the lysine methyltransferase Set7
EF 2013-14
Résumé
The intestine is an amazing organ. It must absorb nutrients from our diet, act as a barrier to germs we ingest, respond when we get infected but ignore all of the bacteria and food present. Also, the gut is constantly growing, with cells dividing and dying constantly. Thus, it requires a lot of regulation to make sure cells don't start dividing too much, which would result in cancer. Indeed, colon cancer is one of the most common forms of cancer in the world. In this proposal, we study a novel pathway that regulates intestinal cell growth and death. We have identified a protein called Set7 that chemically modifies other proteins to affect their function. In the case of Set7, it adds a "methyl group" and is thus called a methyltransferase. We have identified the proteins Set7 modifies and it turns out they are critical for normal gut function as well as cancer development. The results of these studies will define new therapeutic targets to potentially treat or prevent colon cancer.
Programme
Operating Grant
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
290050
Name
Zaph Colby
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Cancer Biology & Therapeutics
Projecttitle
Regulation of intestinal homeostasis and cancer by the lysine methyltransferase Set7
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$795,064
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Beta-Catenin; Cancer; Cell Biology; Hippo Pathway; Intestine; Liver; Lysine Methylation; Organoids; Set7; Wnt Pathway
Abstract
The intestine is an amazing organ. It must absorb nutrients from our diet, act as a barrier to germs we ingest, respond when we get infected but ignore all of the bacteria and food present. Also, the gut is constantly growing, with cells dividing and dying constantly. Thus, it requires a lot of regulation to make sure cells don't start dividing too much, which would result in cancer. Indeed, colon cancer is one of the most common forms of cancer in the world. In this proposal, we study a novel pathway that regulates intestinal cell growth and death. We have identified a protein called Set7 that chemically modifies other proteins to affect their function. In the case of Set7, it adds a "methyl group" and is thus called a methyltransferase. We have identified the proteins Set7 modifies and it turns out they are critical for normal gut function as well as cancer development. The results of these studies will define new therapeutic targets to potentially treat or prevent colon cancer.
Competitiondate
201309
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Zaph, Colby
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $795,064~ $0~